Document Detail

Physiological concentrations of bile acids down-regulate agonist induced secretion in colonic epithelial cells.
MedLine Citation:
PMID:  19583809     Owner:  NLM     Status:  MEDLINE    
In patients with bile acid malabsorption, high concentrations of bile acids enter the colon and stimulate Cl(-) and fluid secretion, thereby causing diarrhoea. However, deoxycholic acid (DCA), the predominant colonic bile acid, is normally present at lower concentrations where its role in regulating transport is unclear. Thus, the current study set out to investigate the effects of physiologically relevant DCA concentrations on colonic epithelial secretory function. Cl(-) secretion was measured as changes in short-circuit current across voltage-clamped T(84) cell monolayers. At high concentrations (0.5-1 mM), DCA acutely stimulated Cl(-) secretion but this effect was associated with cell injury, as evidenced by decreased transepithelial resistance (TER) and increased lactate dehydrogenase (LDH) release. In contrast, chronic (24 hrs) exposure to lower DCA concentrations (10-200 microM) inhibited responses to Ca(2+) and cAMP-dependent secretagogues without altering TER, LDH release, or secretagogue-induced increases in intracellular second messengers. Other bile acids - taurodeoxycholic acid, chenodeoxycholic acid and cholic acid - had similar antisecretory effects. DCA (50 microM) rapidly stimulated phosphorylation of the epidermal growth factor receptor (EGFr) and both ERK and p38 MAPKs (mitogen-activated protein kinases). The EGFr inhibitor, AG1478, and the protein synthesis inhibitor, cycloheximide, reversed the antisecretory effects of DCA, while the MAPK inhibitors, PD98059 and SB203580, did not. In summary, our studies suggest that, in contrast to its acute prosecretory effects at pathophysiological concentrations, lower, physiologically relevant, levels of DCA chronically down-regulate colonic epithelial secretory function. On the basis of these data, we propose a novel role for bile acids as physiological regulators of colonic secretory capacity.
Niamh Keating; Magdalena S Mroz; Michael M Scharl; Christine Marsh; Gail Ferguson; Alan F Hofmann; Stephen J Keely
Related Documents :
11142579 - Therapeutic effects of an oral adsorbent on acute dextran sulphate sodium-induced colit...
6831999 - Tauroursodeoxycholic acid is less damaging than taurochenodeoxycholic acid to the gastr...
3660159 - The effect of secretin on duodenogastric reflux in vagotomised dogs.
15304119 - Effects of colchicine on the maximum biliary excretion of cholephilic compounds in rats.
17136859 - Biosynthesis of bile acids in mammalian liver.
7766669 - Enzymatic characterization of a novel bovine liver dihydrodiol dehydrogenase--reaction ...
2400769 - The histones of the insect trypanosomatid, crithidia fasciculata.
23185239 - Resolving discrepancy between nucleotides and amino acids in deep-level arthropod phylo...
25177929 - When gold meets chiral brønsted acid catalysts: extending the boundaries of enantiosel...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2009-07-06
Journal Detail:
Title:  Journal of cellular and molecular medicine     Volume:  13     ISSN:  1582-4934     ISO Abbreviation:  J. Cell. Mol. Med.     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2010-02-09     Completed Date:  2010-07-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101083777     Medline TA:  J Cell Mol Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  2293-303     Citation Subset:  IM    
Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bile Acids and Salts / physiology*
Cell Line
Colon / cytology,  secretion*
Intestinal Mucosa / cytology,  secretion
Grant Support
Reg. No./Substance:
0/Bile Acids and Salts

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-bi...
Next Document:  The immune boundaries for stem cell based therapies: problems and prospective solutions.